 Artist: Garden Wall: mp3 download Genre(s): Metal: Progressive Discography:  Path of Dreams Year: 1994 Tracks: 11 Although this Italian neo-progressive band has interpreted their name from one of the monikers Genesis played under in their earlier years, Garden Wall is far from being fundamentally a Genesis tribute band. Increasingly complex and heavy over the years, the group, lED by guitar player, keyboardist, and vocalizer Alessandro Seravalle, has as well experimented with identical gothic looking instrumentals. Garden Wall's first album, Principium (1993) institute the band in a very embryonic phase just hinting at the harder and more symphonious influence to come piece defintely rooting the chemical group in seventies trend progressive rock. Path of Dreams (1994) showed the mathematical group had matured greatly, on the job with increasingly complex and dynamical arrangements including on various instrumentals. 1995's The Seduction of Madness affected towards a heavier sound while Chimica (1997) consolidated unitedly their newfound harder edge with respective more quiet book of Numbers. With the collapse of their label in 1999, the band's fifth record album, Forget the Colors, was leftfield unreleased. They feature stated the record book would be their well-nigh complex and clayey to day of the month, simply with difficulties trying to find a new label the release has been postponed. |
Thursday, 21 August 2008
Download Garden Wall mp3
Monday, 11 August 2008
Joy
Artist: Joy
Genre(s):
New Age
Dance
Pop
Discography:
Hymns and Songs in Sanskrit
Year: 2006
Tracks: 11
Full of joy
Year: 2002
Tracks: 10
3rd
Year: 2002
Tracks: 11
Collection
Year: 2001
Tracks: 16
Best Songs and Remixes (Unofficial Release)
Year: 2001
Tracks: 15
Felicidad CD5
Year: 1995
Tracks: 3
Joy and Tears
Year: 1986
Tracks: 10
Hello
Year: 1986
Tracks: 8
Wednesday, 6 August 2008
Pharmacies In London To Run Mobile Smoking Cessation Campaigns Via SMS
�Pharmacies in London will launch a text messaging service to validate smoking status and invite 'quitters' for smoke cessation services in gain to victimisation the system of rules for 'follow-up' over the next yr. The borrowing of the Patient Care Messaging service, provided by iPLATO, has been driven by the successful usance of the system for similar campaigns in GP surgeries across 34 PCTs.
The pharmacies using iPLATO's Patient Care Messaging for Pharmacies service, will obtain support via best exercise techniques for launching the text electronic messaging service, enabling them to fulfil their growing role in Public Health.
A representative from one of the pharmacies said, "We are unrestrained about the opportunity to improve engagement with our patients through innovative applied science. For whatsoever broad patient communication solvent we are always interested with secrecy and data protection. The PCT has developed guidelines to assure patient safety that we adhere to. According to these guidelines, patients lav opt out of the service at any time by plainly telling their pharmacist or any staff. We would encourage all customers to hand in their mobile number so that we can attain them with this new service."
"We are captivated to support pharmacies delivering public health services" aforesaid Tobias Alpsten, Managing Director for iPLATO. "Through our technology and knowledge we can lease pharmacies benefit from our experience of overseeing loads of mobile smoking surcease campaigns. This will enable them to better serve their communities and improve their businesses. In the first stagecoach we aim to enable targeted smoking cessation campaigns. In the future, we expect to grow the platform to automated services such as repeat prescription and medication reminders. We hope to create receipts share based partnerships with pharmacy direction systems to achieve this goal."
About iPLATO
iPLATO is a privately owned limited party founded in London in the autumn of 1999. In 2003, iPLATO was awarded a SMART Feasibility Grant by the Department of Trade & Industry to study the feasibleness for national implementation of a scheme to prompt outpatients close to scheduled appointments using text messaging technology.
Since complemental the study, the company has invested substantial resources towards overcoming the barriers to launching of the healthcare market place and now provides successful healthcare solutions to NHS organisations end-to-end the United Kingdom - building a promising business around its flagship service 'Patient Care Messaging'.
The European Venture Contest, unionized by the European Commission, recognised iPLATO as one of the top ten early stage technology ventures ready to "reshape their industry and to seize the worldwide market" and featured on the Red Herring Europe Top cc of companies to keep an eye on in 2006. iPLATO began 2008 with extensive (PCT funded) roll out of Patient Care Messaging to GP surgeries across 10 Primary Care Trusts.
iPLATO
1 Hammersmith Grove, London W6 0NB, United Kingdom
http://www.iplato.net
More information
The pharmacies using iPLATO's Patient Care Messaging for Pharmacies service, will obtain support via best exercise techniques for launching the text electronic messaging service, enabling them to fulfil their growing role in Public Health.
A representative from one of the pharmacies said, "We are unrestrained about the opportunity to improve engagement with our patients through innovative applied science. For whatsoever broad patient communication solvent we are always interested with secrecy and data protection. The PCT has developed guidelines to assure patient safety that we adhere to. According to these guidelines, patients lav opt out of the service at any time by plainly telling their pharmacist or any staff. We would encourage all customers to hand in their mobile number so that we can attain them with this new service."
"We are captivated to support pharmacies delivering public health services" aforesaid Tobias Alpsten, Managing Director for iPLATO. "Through our technology and knowledge we can lease pharmacies benefit from our experience of overseeing loads of mobile smoking surcease campaigns. This will enable them to better serve their communities and improve their businesses. In the first stagecoach we aim to enable targeted smoking cessation campaigns. In the future, we expect to grow the platform to automated services such as repeat prescription and medication reminders. We hope to create receipts share based partnerships with pharmacy direction systems to achieve this goal."
About iPLATO
iPLATO is a privately owned limited party founded in London in the autumn of 1999. In 2003, iPLATO was awarded a SMART Feasibility Grant by the Department of Trade & Industry to study the feasibleness for national implementation of a scheme to prompt outpatients close to scheduled appointments using text messaging technology.
Since complemental the study, the company has invested substantial resources towards overcoming the barriers to launching of the healthcare market place and now provides successful healthcare solutions to NHS organisations end-to-end the United Kingdom - building a promising business around its flagship service 'Patient Care Messaging'.
The European Venture Contest, unionized by the European Commission, recognised iPLATO as one of the top ten early stage technology ventures ready to "reshape their industry and to seize the worldwide market" and featured on the Red Herring Europe Top cc of companies to keep an eye on in 2006. iPLATO began 2008 with extensive (PCT funded) roll out of Patient Care Messaging to GP surgeries across 10 Primary Care Trusts.
iPLATO
1 Hammersmith Grove, London W6 0NB, United Kingdom
http://www.iplato.net
More information
- Likeable celebrities: Best brands
- MDA Activities Focus Attention On National ALS Awareness Month
- Visually Impaired May Soon Benefit FromTelescope Embedded In Glasses Lens
- California Courts Consider Effects Of Medicaid Fee Reductions For Pharmacists
- Fourth International Consultation On Incontinence (ICI) - Surgery For Urinary Incontinence In Men Committee Highlights
Subscribe to:
Posts (Atom)